Ether derivative

Details Ether derivative Ether derivative

2006-04-13

2010-06-01

Davis, Zinna N (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S143000

Reexamination Certificate

active

07728005

ABSTRACT:
The present invention relates to an ether derivative represented by the formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereofwherein each symbol is as defined in the description, and an ether derivative represented by the formula (III), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereofwherein each symbol is as defined in the description; a pharmaceutical composition containing the ether derivative; and a package containing the pharmaceutical composition and a description of use thereof. A pharmaceutical composition of the present invention, which contains this compound of the present invention has a superior anti-inflammatory and analgesic activity and is useful as various pharmaceutical agents such as an anti-inflammatory agent, an analgesic, a therapeutic agent for inflammatory bowel disease, a therapeutic agent for pollakiuria and/or incontinentia, a therapeutic agent for asthma and the like.

REFERENCES:
patent: 3535328 (1970-10-01), Zielinski
patent: 2003/0158188 (2003-08-01), Lee et al.
patent: 2003/0158198 (2003-08-01), Lee et al.
patent: 1 190 710 (2002-03-01), None
patent: 2 065 121 (1981-06-01), None
patent: WO 94/06770 (1994-03-01), None
patent: WO 00/50387 (2000-08-01), None
patent: WO 01/07409 (2001-02-01), None
patent: WO 01/70734 (2001-09-01), None
patent: WO 02/08221 (2002-01-01), None
patent: WO 02/16317 (2002-02-01), None
patent: WO 02/16318 (2002-02-01), None
patent: WO 02/16319 (2002-02-01), None
patent: WO 02/072536 (2002-09-01), None
patent: WO 02/090326 (2002-11-01), None
patent: WO 03/014064 (2003-02-01), None
patent: WO 03/022809 (2003-03-01), None
patent: WO 03/027064 (2003-04-01), None
patent: WO 03/053945 (2003-07-01), None
patent: WO 03/055484 (2003-07-01), None
patent: WO 03/055848 (2003-07-01), None
patent: WO 03/070247 (2003-08-01), None
patent: WO 03/080578 (2003-10-01), None
patent: WO 03/095420 (2003-11-01), None
patent: WO 03/097586 (2003-11-01), None
patent: WO 2004/007459 (2004-01-01), None
patent: WO 2004/024710 (2004-03-01), None
patent: WO 2004/028440 (2004-04-01), None
patent: WO 2004/052845 (2004-06-01), None
patent: WO 2004/052846 (2004-06-01), None
Venkatachalam et al, Bioorganic & Medicinal Chemistry Letters, (2001), vol. 11, pp. 523-528.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Leallyn B. Clapp. “Reactions of Ethylenimines. III. With Phenols”, Journal of the American Chemical Society, vol. 73, XP-002458712, 1951, pp. 2584-2586.
D.G. Hayman et al.; “Hypoglycaemic agents”; J. Pharm. Pharmacol., vol. 16, pp. 538-548; 1964.
CAplus, DN: 64:75542, T. Agawa et al., “Thermal decomposition of adducts from isocyanates and diethyl malonate”, Kogyo Kagaku Zasshi, 1965, 68(12), pp. 2370-2373.
D. Uzunov et al.; “Some aspects of the enantiorecognition of derivatized primary amines on a Pirkle-type chiral stationary phase utilizing tocainide and mexiletine as model compounds”; Journal of Chromatography, 1993. 645, pp. 233-239.

Affiliated with

Also associated with

Rating

Ether derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ether derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ether derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4246092